Inhibitory Antibodies Designed for Matrix Metalloproteinase Modulation.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
18 Jun 2019
Historique:
received: 07 05 2019
revised: 13 06 2019
accepted: 14 06 2019
entrez: 21 6 2019
pubmed: 21 6 2019
medline: 30 11 2019
Statut: epublish

Résumé

The family of matrix metalloproteinases (MMPs) consists of a set of biological targets that are involved in a multitude of severe pathogenic events such as different forms of cancers or arthritis. Modulation of the target class with small molecule drugs has not led to the anticipated success until present, as all clinical trials failed due to unacceptable side effects or a lack of therapeutic outcome. Monoclonal antibodies offer a tremendous therapeutic potential given their high target selectivity and good pharmacokinetic profiles. For the treatment of a variety of diseases there are already antibody therapies available and the number is increasing. Recently, several antibodies were developed for the selective inhibition of single MMPs that showed high potency and were therefore investigated in in vivo studies with promising results. In this review, we highlight the progress that has been achieved toward the design of inhibitory antibodies that successfully modulate MMP-9 and MMP-14.

Identifiants

pubmed: 31216704
pii: molecules24122265
doi: 10.3390/molecules24122265
pmc: PMC6631688
pii:
doi:

Substances chimiques

Antibodies, Monoclonal 0
Matrix Metalloproteinase Inhibitors 0
Matrix Metalloproteinases EC 3.4.24.-

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : ZHAW
ID : 9710.3.18.5.0179

Références

Ann N Y Acad Sci. 1999 Jun 30;878:73-91
pubmed: 10415721
J Biol Chem. 1999 Jul 30;274(31):21491-4
pubmed: 10419448
Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10863-8
pubmed: 10485917
Gut. 2000 Jul;47(1):57-62
pubmed: 10861265
J Med Chem. 2000 Sep 7;43(18):3377-85
pubmed: 10978185
J Mol Biol. 2001 Mar 23;307(2):577-86
pubmed: 11254383
J Med Chem. 2001 Mar 29;44(7):1060-71
pubmed: 11297453
Chem Rev. 1999 Sep 8;99(9):2735-76
pubmed: 11749499
Int J Cancer. 2002 Feb 1;97(4):425-31
pubmed: 11802202
Chem Rev. 1997 Aug 5;97(5):1359-1472
pubmed: 11851455
Nat Rev Cancer. 2002 Sep;2(9):657-72
pubmed: 12209155
Cancer Metastasis Rev. 2003 Jun-Sep;22(2-3):177-203
pubmed: 12784996
J Comput Aided Mol Des. 2003 Sep;17(9):551-65
pubmed: 14713188
J Mol Biol. 2004 Feb 6;336(1):213-25
pubmed: 14741217
Biochem Pharmacol. 2004 Mar 1;67(5):1001-9
pubmed: 15104254
Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5334-9
pubmed: 15809432
J Cell Mol Med. 2005 Apr-Jun;9(2):267-85
pubmed: 15963249
J Invest Dermatol. 2006 Feb;126(2):486-96
pubmed: 16374453
Cardiovasc Res. 2006 Feb 15;69(3):562-73
pubmed: 16405877
Br J Cancer. 2006 Apr 10;94(7):941-6
pubmed: 16538215
Cancer Metastasis Rev. 2006 Mar;25(1):115-36
pubmed: 16680577
Chem Rev. 2006 Aug;106(8):3279-301
pubmed: 16895328
Biochim Biophys Acta. 2007 Feb;1770(2):178-86
pubmed: 17137715
Reproduction. 2007 Feb;133(2):405-14
pubmed: 17307908
FASEB J. 2007 Aug;21(10):2580-91
pubmed: 17392479
J Biol Chem. 2007 Sep 21;282(38):27781-91
pubmed: 17623656
Semin Cell Dev Biol. 2008 Feb;19(1):34-41
pubmed: 17707664
Cancer Res. 2009 Feb 15;69(4):1517-26
pubmed: 19208838
Cancer Biol Ther. 2009 Dec;8(24):2362-70
pubmed: 19855192
Biochim Biophys Acta. 2010 Jan;1803(1):55-71
pubmed: 20080133
Nat Rev Drug Discov. 2010 Apr;9(4):325-38
pubmed: 20305665
Biochemistry. 2010 Jul 27;49(29):6184-92
pubmed: 20545310
Biochem Res Int. 2011;2011:191670
pubmed: 21152183
ChemMedChem. 2011 May 2;6(5):769-73
pubmed: 21520417
EMBO Mol Med. 2011 Jul;3(7):367-9
pubmed: 21591260
Proc Natl Acad Sci U S A. 1990 Jul;87(14):5578-82
pubmed: 2164689
Pharmacol Res. 2011 Dec;64(6):590-4
pubmed: 21742038
Genome Biol. 2011 Nov 11;12(11):233
pubmed: 22078297
Nat Med. 2011 Dec 25;18(1):143-7
pubmed: 22198278
J Biol Chem. 2012 May 4;287(19):15935-46
pubmed: 22427646
J Biol Chem. 2013 Jan 11;288(2):1307-16
pubmed: 23184939
J Biol Chem. 2013 Apr 12;288(15):10195-204
pubmed: 23413031
Cancer Res. 2013 Apr 15;73(8):2457-2467
pubmed: 23423981
Biochem Biophys Res Commun. 2013 Nov 8;441(1):226-9
pubmed: 24140051
Oncogenesis. 2013 Dec 02;2:e80
pubmed: 24296749
Biochim Biophys Acta. 2014 Aug;1840(8):2571-80
pubmed: 24631662
PLoS One. 2014 Apr 11;9(4):e94318
pubmed: 24727739
Nat Rev Rheumatol. 2014 Oct;10(10):593-601
pubmed: 24914698
J Med Chem. 2014 Dec 26;57(24):10205-19
pubmed: 25265401
Structure. 2015 Jan 6;23(1):104-115
pubmed: 25482542
Structure. 2015 Jan 6;23(1):6-7
pubmed: 25565101
Ann Med Surg (Lond). 2014 Sep 11;3(4):113-6
pubmed: 25568796
Matrix Biol. 2015 May-Jul;44-46:200-6
pubmed: 25652204
Matrix Biol. 2015 May-Jul;44-46:167-74
pubmed: 25686691
J Natl Cancer Inst. 2015 Feb 20;107(4):null
pubmed: 25710962
Matrix Biol. 2015 May-Jul;44-46:247-54
pubmed: 25805621
Adv Wound Care (New Rochelle). 2015 Apr 1;4(4):225-234
pubmed: 25945285
Mol Cancer Ther. 2015 Jul;14(7):1637-49
pubmed: 25948294
PLoS One. 2015 May 11;10(5):e0127063
pubmed: 25961845
Biomed Res Int. 2015;2015:428169
pubmed: 26075239
Genes Dis. 2015 Mar 1;2(`1):26-34
pubmed: 26097889
Nat Rev Rheumatol. 2015 Oct;11(10):606-15
pubmed: 26195338
J Med Chem. 2015 Sep 24;58(18):7224-40
pubmed: 26263024
Oncotarget. 2016 Mar 29;7(13):16773-92
pubmed: 26934448
J Enzyme Inhib Med Chem. 2016;31(sup1):177-183
pubmed: 27028474
Sci Rep. 2016 Apr 22;6:24789
pubmed: 27102061
Sci Rep. 2016 May 17;6:26245
pubmed: 27185050
Reproduction. 2016 Jul;152(1):11-22
pubmed: 27256632
Crit Rev Biochem Mol Biol. 2016 Sep;51(5):295-358
pubmed: 27362691
Chembiochem. 2016 Oct 17;17(20):1892-1899
pubmed: 27477215
Inflamm Bowel Dis. 2016 Sep;22(9):2041-57
pubmed: 27542125
Oncotarget. 2017 Jan 10;8(2):2781-2799
pubmed: 27835863
Int J Mol Sci. 2016 Nov 18;17(11):
pubmed: 27869733
Proc Natl Acad Sci U S A. 2016 Dec 27;113(52):14970-14975
pubmed: 27965386
J Med Chem. 2017 Jan 26;60(2):608-626
pubmed: 27966948
Protein Eng Des Sel. 2017 Feb;30(2):113-118
pubmed: 27986919
J Biol Chem. 2017 Feb 24;292(8):3481-3495
pubmed: 28087697
Biotechnol Bioeng. 2017 Jun;114(6):1140-1150
pubmed: 28090632
J Biol Chem. 2017 Apr 21;292(16):6810-6820
pubmed: 28235803
Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt A):2036-2042
pubmed: 28502592
Eur J Pharm Sci. 2017 Dec 15;110:62-69
pubmed: 28554668
Oncotarget. 2017 May 9;8(35):58372-58385
pubmed: 28938563
Expert Opin Drug Discov. 2018 Jan;13(1):75-87
pubmed: 29088927
J Gene Med. 2018 Jan;20(1):
pubmed: 29165854
Clin Cancer Res. 2018 Aug 15;24(16):3829-3837
pubmed: 29691300
Mol Cancer Ther. 2018 Jun;17(6):1147-1155
pubmed: 29735645
Cancers (Basel). 2018 Jun 05;10(6):null
pubmed: 29874869
Nat Rev Drug Discov. 2018 Jul;17(7):509-527
pubmed: 29904196
Oncotarget. 2018 Jun 29;9(50):29431-29444
pubmed: 30034628
Biotechnol Bioeng. 2018 Nov;115(11):2673-2682
pubmed: 30102763
Protein Sci. 2019 Mar;28(3):643-653
pubmed: 30592555
Angew Chem Int Ed Engl. 2019 Mar 18;58(12):4051-4055
pubmed: 30615822
Chemistry. 2019 Jun 18;25(34):7960-7980
pubmed: 30720221
J Biol Chem. 1995 May 12;270(19):11555-66
pubmed: 7744795
Biochemistry. 1995 May 23;34(20):6602-10
pubmed: 7756291
Proteins. 1994 Jun;19(2):98-109
pubmed: 8090713
FEBS Lett. 1993 Sep 27;331(1-2):134-40
pubmed: 8405391
Eur J Biochem. 1995 Dec 15;234(3):759-65
pubmed: 8575432
Structure. 1995 Jun 15;3(6):527-30
pubmed: 8590012
Biochemistry. 1977 May 31;16(11):2506-16
pubmed: 861218
Biochemistry. 1996 May 28;35(21):6549-58
pubmed: 8639603
Circulation. 1997 Jan 7;95(1):205-12
pubmed: 8994438
Genomics. 1998 Aug 15;52(1):101-6
pubmed: 9740677
Curr Opin Cell Biol. 1998 Oct;10(5):602-8
pubmed: 9818170
J Mol Biol. 1998 Dec 11;284(4):1133-40
pubmed: 9837731

Auteurs

Thomas Fischer (T)

Institute of Chemistry and Biotechnology, Center of Organic and Medicinal Chemistry, Zurich University of Applied Sciences, Einsiedlerstrasse 31, 8820 Wädenswil, Switzerland. thomas.fischer@zhaw.ch.

Rainer Riedl (R)

Institute of Chemistry and Biotechnology, Center of Organic and Medicinal Chemistry, Zurich University of Applied Sciences, Einsiedlerstrasse 31, 8820 Wädenswil, Switzerland. rainer.riedl@zhaw.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH